BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 27262492)

  • 41. Long non-coding RNA DANCR accelerates colorectal cancer progression via regulating the miR-185-5p/HMGA2 axis.
    Lu W; Huang Z; Wang J; Liu H
    J Biochem; 2022 Mar; 171(4):389-398. PubMed ID: 33481014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

  • 45. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
    Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
    Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
    World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
    Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
    Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
    Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
    Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
    Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
    Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Overexpression of high mobility group A2 and its correlation with microRNA let-7 family in serous ovarian cancers].
    Yang J; Zhang Q; Dong JQ; Chang XH; He XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):749-54. PubMed ID: 23073586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
    Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
    BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. XIAP 3'-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinoma.
    Wu WY; Tao SQ; Wang XN; Lobie PE; Wu ZS
    Tumour Biol; 2017 Jul; 39(7):1010428317719578. PubMed ID: 28691642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs.
    Liu Q; Liu T; Zheng S; Gao X; Lu M; Sheyhidin I; Lu X
    Histopathology; 2014 Sep; 65(3):408-17. PubMed ID: 24612219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
    Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
    Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
    Yan S; Jiang Y; Liang C; Cheng M; Jin C; Duan Q; Xu D; Yang L; Zhang X; Ren B; Jin P
    J Cell Biochem; 2018 May; 119(5):4113-4119. PubMed ID: 29240249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.